Cognitive bias modification of interpretations: A viable treatment for child and adolescent anxiety?

Cognitive bias modification of interpretations: A viable treatment for child and adolescent anxiety?
复制标题

DOI:
10.1016/j.brat.2013.07.001
复制
发表时间:
2013-10-01
影响因子:
4.1
通讯作者:
Lau, Jennifer Y. F.
Lau, Jennifer Y. F.
中科院分区:
心理学2区
文献类型:
--
作者:
Lau, Jennifer Y. F.

文献摘要

被引文献

相似文献

儿童和青少年的焦虑症很常见,而且会造成损害。由于许多患者不能从一线治疗中受益,或者难以获得一线治疗,因此需要新颖、有效和易于实施的干预措施。认知偏差修正解释(CBM-I)训练已被用于治疗成人焦虑症。CBM-I方法训练个体认同对模棱两可线索的良性解决方案,而不是消极解决方案。由于几个原因,CBM-I的发展扩展很重要。首先,在有症状的儿童和青少年中实施CBM-I可促进早期预防成果。其次,由于训练使用简单的学习机制,CBM-I可能反映了一种适合发展的策略来形成适应性加工风格。第三,由于这个年龄段涉及到长期的神经认知成熟和相关的可塑性,早期实施CBM-I可以为情感发展带来强大而持久的好处。最后,CBM-I研究的数据可以为早期出现焦虑的认知机制提供信息。本文首次对在儿童和青少年中进行的CBM-I研究进行了有组织的回顾,并包含了对未来研究的建议,这些研究可能有助于实现早期CBM-I干预的治疗潜力。(C) 2013 Elsevier Ltd.版权所有。
Anxiety disorders in children and adolescents are common and impairing. As many patients do not benefit from - or have difficulties accessing - frontline treatments, novel, effective and easy-to-deliver interventions are needed. Cognitive Bias Modification of Interpretations (CBM-I) training has been used to treat adult anxiety disorders. CBM-I methods train individuals to endorse benign rather than negative resolutions of ambiguous cues. Developmental extensions of CBM-I are important for several reasons. First, implementing CBM-I in symptomatic children and adolescents may facilitate early preventative gains. Second, as training uses simple learning mechanisms, CBM-I may reflect a developmentally-suitable strategy for shaping adaptive processing styles. Third, as this age range involves protracted neurocognitive maturation and associated plasticity, administering CBM-I early could drive powerful, long-lasting benefits for emotional development. Finally, data from CBM-I studies could inform the cognitive mechanisms involved in the genesis of early-emerging anxiety. This paper provides the first organised review of CBM-I studies conducted in children and adolescents, and contains suggestions for future research that may help realise the therapeutic potential of early CBM-I interventions. (C) 2013 Elsevier Ltd. All rights reserved.